THE FAVORABLE HEMODYNAMIC RESPONSE TO CARVEDILOL IN HEART FAILURE PATIENTS MIGHT BE COMPROMISED BY TWO ADRENERGIC RECEPTOR POLYMORPHISMS.

被引：0
|
作者：
Zakrzewski-Jakubiak, M. [1 ]
de Denus, S. [1 ]
Leblanc, M. [2 ]
White, M. [2 ]
Turgeon, J. [1 ]
机构：
[1] Univ Montreal, Montreal, PQ, Canada
[2] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S2 / S3
页数：2
相关论文
共 50 条
  • [21] Association of β-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy
    Forleo, C
    Resta, N
    Sorrentino, S
    Guida, P
    Manghisi, A
    De Luca, V
    Romito, R
    Iacoviello, M
    De Tommasi, E
    Troisi, F
    Rizzon, B
    Guanti, G
    Rizzon, P
    Pitzalis, MV
    AMERICAN JOURNAL OF MEDICINE, 2004, 117 (07): : 451 - 458
  • [22] Adrenergic Receptor Polymorphisms and Prevention of Ventricular Arrhythmias With Bucindolol in Patients With Chronic Heart Failure
    Aleong, Ryan G.
    Sauer, William H.
    Robertson, Alastair D.
    Liggett, Stephen B.
    Bristow, Michael R.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2013, 6 (01): : 137 - 143
  • [23] Adrenergic receptor Polymorphisms and prevention of-atrial fibrillation with bucindolol in patients with heart failure
    Sauer, William
    Lowery, Christopher M.
    Budhathoki, Chakra
    Lowes, Brian D.
    Bristow, Michael R.
    CIRCULATION, 2007, 116 (16) : 638 - 638
  • [24] Gln27→Gluβ2-Adrenergic Receptor Polymorphism in Heart Failure Patients: Differential Clinical and Oxidative Response to Carvedilol
    Troncoso, Rodrigo
    Moraga, Francisco
    Chiong, Mario
    Roldan, Juan
    Bravo, Roberto
    Valenzuela, Rodrigo
    Diaz-Araya, Guillermo
    del Campo, Andrea
    Sanhueza, Carlos
    Rodriguez, Andrea
    Vukasovic, Jose Luis
    Mellado, Rosemarie
    Greig, Douglas
    Castro, Pablo F.
    Lavandero, Sergio
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 104 (05) : 374 - 378
  • [25] Role of Beta-Adrenergic Receptor Gene Polymorphisms in the Long-Term Effects of Beta-Blockade with Carvedilol in Patients with Chronic Heart Failure
    Metra, Marco
    Covolo, Loredana
    Pezzali, Natalia
    Zaca, Valerio
    Bugatti, Silvia
    Lombardi, Carlo
    Bettari, Luca
    Romeo, Alessia
    Gelatti, Umberto
    Giubbini, Raffaele
    Donato, Francesco
    Dei Cas, Livio
    CARDIOVASCULAR DRUGS AND THERAPY, 2010, 24 (01) : 49 - 60
  • [26] Role of Beta-Adrenergic Receptor Gene Polymorphisms in the Long-Term Effects of Beta-Blockade with Carvedilol in Patients with Chronic Heart Failure
    Marco Metra
    Loredana Covolo
    Natalia Pezzali
    Valerio Zacà
    Silvia Bugatti
    Carlo Lombardi
    Luca Bettari
    Alessia Romeo
    Umberto Gelatti
    Raffaele Giubbini
    Francesco Donato
    Livio Dei Cas
    Cardiovascular Drugs and Therapy, 2010, 24 : 49 - 60
  • [27] Relationship between beta-1 adrenergic receptor polymorphisms and the response to beta-blockers in patients with heart failure
    De Groote, P
    Lamblin, N
    Helbecque, N
    Lablanche, JM
    Amouyel, P
    Bauters, C
    Dallongeville, J
    CIRCULATION, 2001, 104 (17) : 661 - 662
  • [28] Pharmacogenetics and response to β-adrenergic receptor antagonists in heart failure
    Muszkat, M
    Stein, CM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (03) : 123 - 126
  • [29] Adrenergic Receptor Polymorphisms in Heart Failure: what Can Genetics Explain?
    Pereira, Sabrina Bernardez
    Gava, Isabela Ambrosio
    Giro, Camila
    Mesquita, Evandro Tinoco
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2010, 94 (06) : 841 - 849
  • [30] Statins and Response to Carvedilol Given to Patients with Chronic Heart Failure
    Nessler, Bohdan J.
    Golebiowska, Renata
    Gackowski, Andrzej
    Nessler, Jadwiga M.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (08) : S75 - S75
12345